| Authors: |
Tanaka M; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Idei M; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Sakaguchi H; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Kato R; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Sato D; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Sawanobori K; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Kawarasaki S; Office of New Drug 2, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Hata T; Office of New Drug 3, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Yoshizaki A; Office of New Drug 4, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Nakamura M; Office of New Drug 5, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Ikuma M; Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. |
